(Press-News.org) A new study shows that walking reduces risk of functional limitation associated with knee osteoarthritis (OA). In fact, the study funded in part by grants from the National Institutes of Health (NIH) and published in the American College of Rheumatology (ACR) journal, Arthritis Care & Research, suggests that walking 6,000 or more steps per day may protect those with or at risk of knee of OA from developing mobility issues, such as difficulty getting up from a chair and climbing stairs.
Nearly 27 million Americans age 25 and older are diagnosed with OA according to a prevalence study by Lawrence et al. (Arthritis Rheum, 2008). Previous research reports that knee OA is the leading cause of functional limitation among older adults, making walking and climbing stairs difficult. Moreover, data from the National Health and Nutrition Examination Survey (NHANES III) state that 80% of OA patients have some limitation in movement, with 11% of adults with knee OA needing assistance with personal care assistance.
While walking is a common daily physical activity for older adults, medical evidence reports that two-thirds of U.S. adults with arthritis walk less than 90 minutes each week. "Our study examines if more walking equates with better functioning, and if so, how much daily walking is needed to minimize risk of developing problems with mobility in people with knee OA," said Daniel White, PT, ScD, from Sargent College at Boston University in Massachusetts.
For the present study, researchers measured daily steps taken by 1788 people with or at risk for knee OA, who were part of the Multicenter Osteoarthritis Study. Walking was measured with a monitor over seven days and functional limitation evaluated two years later, defined as a slow walking speed and a Western Ontario and McMaster Universities Arthritis Index (WOMAC) physical function score greater than 28 out of 68.
Walking an additional 1,000 steps each was associated with between a 16% to 18% reduction in incident functional limitation two years later. Walking less than 6,000 steps daily was the best threshold for identifying those who developed functional limitation.
Dr. White concludes, "Walking is an inexpensive activity and despite the common popular goal of walking 10,000 steps per day, our study finds only 6,000 steps are necessary to realize benefits. We encourage those with or at risk of knee OA to walk at least 3,000 or more steps each day, and ultimately progress to 6,000 steps daily to minimize the risk of developing difficulty with mobility."
INFORMATION:
Funding for this study was provided by the following sources: NIH AG18820, AG 18832, AG 18947, AG 19069, AR007598, NIH AR47785, NIAMS R01AR062506, ACR/RRF Rheumatology Investigator Award, the Boston Rehabilitation Outcomes Center (Boston ROC) R24HD0065688, the Boston Claude D. Pepper Older Americans Independence Center 1P30AG031679 and the Foundation for Physical Therapy Geriatric Research Grant.
This study is published in Arthritis Care & Research. Media wishing to receive a PDF of this article may contact sciencenewsroom@wiley.com.
Full citation:"Daily Walking and The Risk of Incident Functional Limitation in Knee OA: An Observational Study." Daniel K. White, Catrine Tudor-Locke, Yuqing Zhang, Roger Fielding, Michael LaValley, David T. Felson, K. Douglas Gross, Michael C. Nevitt, Cora E. Lewis, James Torner and Tuhina Neogi. Arthritis Care and Research; Published Online: June 12, 2014 (DOI: 10.1002/acr.22362).
URL Upon Publication: http://doi.wiley.com/10.1002/acr.22362
Author Contact: To arrange an interview with Dr. White, please contact Stephanie Rotondo, with Boston University at rotondos@bu.edu.
About the Journal
Arthritis Care & Research is an official journal of the American College of Rheumatology (ACR), and the Association of Rheumatology Health Professionals (ARHP), a division of the College. Arthritis Care & Research is a peer-reviewed journal that publishes both original research and review articles that promote excellence in the clinical practice of rheumatology. Relevant to the care of individuals with arthritis and related disorders, major topics are evidence-based practice studies, clinical problems, practice guidelines, health care economics, health care policy, educational, social, and public health issues, and future trends in rheumatology practice. The journal is published by Wiley on behalf of the ACR. For more information, please visit the journal home page at http://wileyonlinelibrary.com/journal/acr.
About Wiley
Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.
Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company's website can be accessed at http://www.wiley.com.
6,000 steps a day keeps knee OA limitations away
2014-06-12
ELSE PRESS RELEASES FROM THIS DATE:
Low cholesterol linked with worse survival in patients with kidney cancer
2014-06-12
People are often told to reduce their cholesterol to improve their heart health, but new research suggests that low cholesterol may increase kidney cancer patients' risk of dying from their disease. The findings, which are published in BJU International, indicate that cholesterol testing may help doctors as they monitor and treat patients with kidney cancer.
Increasing evidence suggests that alterations in cholesterol and other lipids are associated with the development, progression, and prognosis of various cancers. To assess the situation as it relates to kidney cancer, ...
Scientists weed out pesky poison ivy with discovery of killer fungus
2014-06-12
Much to the chagrin of gardeners, hikers, and virtually anyone enjoying the outdoors, one of the hazards of summer is picking up an itchy poison ivy rash.
But researchers in the Virginia Tech College of Agriculture and Life Sciences have found a natural and effective way to kill poison ivy using a naturally occurring fungus that grows on the fleshy tissue surrounding the plant's seed, potentially giving homeowners and forest managers the ability to rid landscapes of the pernicious pest. Their findings could make the maddening itch of the summer season a thing of the ...
Content kingmaker -- quality or webpage position?
2014-06-12
In today's Information Age, it's easy get overwhelmed by online content. On YouTube alone, over 100 hours worth of video is uploaded every minute. Showcasing the most interesting content allows providers to convey a certain level of quality to its audiences and encourages users to stay on the website, consuming content and winning advertising dollars for its provider. However, this influx of information makes it difficult for both content providers and users to determine what is interesting and worth consuming.
Due to the sheer volume of submitted content, some providers ...
Spectrum Health among first to implant neurostimulator for epilepsy
2014-06-12
GRAND RAPIDS, Mich., June 11, 2013 – Spectrum Health is the first health system in Michigan and among the first in the nation to successfully implant a recently FDA-approved device that uses electric stimulation of the brain to treat adult epilepsy patients whose seizures have not responded to medication.
The NeuroPace® Responsive Neurostimulation (RNS®) System is an implantable therapeutic device designed to detect abnormal electrical activity in the brain and respond by delivering imperceptible electrical stimulation to normalize brain activity before an individual ...
Peer influence leads teens to start, stop smoking -- but effect is stronger for starting
2014-06-11
WASHINGTON, DC, June 11, 2014 — Adolescents tend to be more powerful in influencing their friends to start smoking than in helping them to quit, according to sociologists.
In a study of adolescent friendship networks and smoking over time, the researchers found that friends exert influence on their peers to both start and quit smoking, but the influence to start is stronger.
"What we found is that social influence matters — it leads nonsmoking friends into smoking and nonsmoking friends can turn smoking friends into nonsmokers," said Steven Haas, an associate professor ...
Infant immune systems learn fast, but have short memories
2014-06-11
ITHACA, N.Y. – Forgetful immune systems leave infants particularly prone to infections, according to a new Cornell University study. Upending the common theory that weak immune cells are to blame, the study has found that infants' immune systems actually respond to infection with more speed and strength than adults, but the immunities they create fail to last.
Published in the Journal of Immunology, the discovery reveals a new angle immunizations could take in protecting infants and children from infectious diseases.
"The perfect vaccine would be a single dose given ...
Study confirms how the body regulates high levels of CO2 in the blood
2014-06-11
In a recently published study in the journal Experimental Physiology, Brazilian researchers have confirmed the importance of a specific group of neurons found in a region of the brain known as the retrotrapezoid nucleus (RTN) in detecting changes in carbon dioxide (CO2) levels and in modulating the activity of the neuronal groups that control respiratory activity.
Scientists from the Biomedical Sciences Institute of the University of São Paulo (USP) and the School of Dentistry at the São Paulo State University (Unesp) participated in the study.
"CO2 is important for regulating ...
Expert CLABSI guidance adds real world implementation strategies
2014-06-11
CHICAGO (June 1, 2014) – As central-line associated bloodstream infections (CLABSIs) pose a danger to vulnerable patients, infection prevention and control experts released new practical recommendations to assist acute care hospitals in implementing and prioritizing prevention efforts.
The guidance was published in the July issue of Infection Control and Hospital Epidemiology and produced in a collaborative effort led by the Society for Healthcare Epidemiology of America, the Infectious Diseases Society of America, the American Hospital Association, the Association for ...
Coordinated intervention reduced prevalence of drug-resistant CRE in long-term care
2014-06-11
CHICAGO (June 11, 2014) – A new study found a nationwide effort to control carbapenem-resistant Enterobacteriaceae (CRE) in Israel reduced CRE cases by improving compliance of infection control standards and using a coordinated intervention focused on long-term care facilities. The study was published in the July issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
"As the global threat of CRE continues to rise, there is a need to better control and understand this bacteria," said Debby Ben-David, MD, ...
EARTH Magazine: Dueling dinosaurs hit the auction block
2014-06-11
Alexandria, Va. — In 2006, a fossil collector and his crew discovered a rare fossil on private land in Montana's Hell Creek Formation: the bones of two fully articulated dinosaurs that appeared to have died together, locked in battle. The fossil duo — a small, pony-sized carnivorous tyrannosaurid and a slightly larger herbivorous ceratopsian, both now preserved in plaster — became known as the "Montana Dueling Dinosaurs." Last November, the fossils were put on the block at Bonhams auction house in New York City — but they did not sell. Had the set fetched the nearly $9 ...